Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Year-over-year debt growth rate
Latest
-3.95%
↓ 102% vs avg
Percentile
P56
Within normal range
Streak
6 qtr
Consecutive declineDecelerating
Average
187.08%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -3.95% |
| Q3 2025 | -3.74% |
| Q2 2025 | -3.37% |
| Q1 2025 | -1.46% |
| Q4 2024 | 2.14% |
| Q3 2024 | 19.79% |
| Q2 2024 | 7359.21% |
| Q1 2024 | -49.67% |
| Q4 2023 | -32.89% |
| Q3 2023 | -24.24% |
| Q2 2023 | -48.35% |
| Q1 2023 | -49.69% |
| Q4 2022 | -33.04% |
| Q3 2022 | -24.60% |
| Q2 2022 | -19.60% |
| Q1 2022 | 435.36% |
| Q4 2021 | -49.71% |
| Q3 2021 | -32.91% |
| Q2 2021 | -24.58% |
| Q1 2021 | -18.97% |
| Q4 2020 | -15.84% |
| Q3 2020 | -13.52% |
| Q2 2020 | 12.63% |
| Q1 2020 | -10.08% |
| Q4 2019 | 349.48% |
| Q3 2019 | -32.93% |
| Q2 2019 | -24.52% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | -100.00% |
| Q2 2017 | -54.75% |
| Q1 2017 | -31.08% |
| Q4 2016 | -21.69% |
| Q3 2016 | -16.04% |
| Q2 2016 | 36.63% |
| Q1 2016 | 9.07% |